Digestive Remedies in Ireland - New Report Available

From: Fast Market Research, Inc.
Published: Thu Aug 20 2015

Proton pump inhibitors saw further development and brand diversification in 2014 with the launch of two new products. Losec Control by Bayer Ltd was launched in June, while Pfizer Consumer Healthcare introduced its Nexium Control brand into Ireland during August 2014. While Nexium contains esomeprazole 20mg, Losec contains omeprazole 20mg. Each of these products is positioned as a product which can manage reflux and they are supported by widespread in-store promotional activity, with Nexium Control more dominant in this regard. While the development of these products allows greater self-management of the condition among consumers, many of these products are available through chemists/pharmacies only and they are generally stored behind the counter and sold only after consultation with pharmacy staff, limiting their growth potential to a certain extent.

Competitive Landscape

McNeil Healthcare (Ireland) Ltd is the leading player in digestive remedies in Ireland and in 2014 maintained its 28% value share. The company’s continued strong performance is supported by its wide range of brands, including the second-ranked brand Motilium with a 15% value share and fifth-ranked Pepcid with a 4% share. Other less successful brands in the company’s portfolio are of the major names within the specific digestive remedies categories in which they are present. Stugeron, for example, leads in motion sickness remedies, while the company has the two leading brands in diarrhoeal remedies: Imodium with a 62% value share; and Arret with a 25% value share.

Full Report Details at
- http://www.fastmr.com/prod/1031626_digestive_remedies_ireland.aspx?afid=301

Industry Prospects

Digestive remedies in Ireland is expected to increase in value at a CAGR of 2% in constant 2014 terms over the forecast period. The self-management of symptoms is expected to be the driving factor behind this growth as a greater range of products and medicinal ingredients in certain categories such as proton pump inhibitors are expected to override the maturity of the majority of existing categories, with antacids a prime example of a very mature digestive remedies category. The high level of knowledge and trust which the majority of Irish consumers are prepared to place in the advice of their local pharmacists and the retail staff of the local chemist/pharmacies outlets is set to further support this growth and boost the popularity of self-management, self-diagnosis and self-treatment, with Irish consumers gaining confidence in their ability to assess and treat the symptoms of digestive outlets themselves, but more often than not only with the support of their pharmacists.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Digestive Remedies industry in Ireland with research from Euromonitor's team of in-country analysts.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Digestive Remedies in Portugal
- Digestive Remedies in Japan
- Digestive Remedies in the United Arab Emirates
- Digestive Remedies in the Czech Republic
- Digestive Remedies in Denmark
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »